The efficacy and safety of telbivudine in korean patients with chronic hepatitis B

The Korean journal of hepatology

Volumn 13, Issue 4, 2007, Pages 503-512

  Moon, Young Myoung ^a   Hwang, Seong Gyu ^a   Kim, Boo Sung ^a   Rim, Kyu Sung ^a   Cho, Mong ^a   Kim, Dong Joon ^a   Han, Joon Yeol ^a   Kim, Young Seok ^a   Choi, Ho Soon ^a   Ahn, Sang Hoon ^a  

^a Kwandong University College of Medicine   (South Korea)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; ANTIVIRUS AGENT; HEPATITIS B(E) ANTIGEN; LAMIVUDINE; NUCLEOSIDE; PYRIMIDINONE DERIVATIVE; TELBIVUDINE;

ADOLESCENT; ADULT; ANTIVIRAL RESISTANCE; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFECT; FEMALE; GENETICS; HEPATITIS B; HEPATITIS B VIRUS; HUMAN; ISOLATION AND PURIFICATION; KOREA; MALE; MIDDLE AGED; PHASE 3 CLINICAL TRIAL; RANDOMIZED CONTROLLED TRIAL; TREATMENT OUTCOME; VIROLOGY;

ADOLESCENT; ADULT; ALANINE TRANSAMINASE; ANTIVIRAL AGENTS; DRUG RESISTANCE, VIRAL; FEMALE; HEPATITIS B E ANTIGENS; HEPATITIS B VIRUS; HEPATITIS B, CHRONIC; HUMANS; KOREA; LAMIVUDINE; MALE; MIDDLE AGED; NUCLEOSIDES; PYRIMIDINONES; TREATMENT OUTCOME;

EID: 61549135819     PISSN: 1738222X     EISSN: None     Source Type: Journal    
DOI: 10.3350/kjhep.2007.13.4.503     Document Type: Article

References (0)